These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Nephrotoxic potential of selective cyclooxygenase-2 inhibitors. Sandhu GK; Heyneman CA Ann Pharmacother; 2004 Apr; 38(4):700-4. PubMed ID: 14982980 [TBL] [Abstract][Full Text] [Related]
13. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Mamdani M; Juurlink DN; Lee DS; Rochon PA; Kopp A; Naglie G; Austin PC; Laupacis A; Stukel TA Lancet; 2004 May; 363(9423):1751-6. PubMed ID: 15172772 [TBL] [Abstract][Full Text] [Related]
14. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791 [TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase (COX-2) selective inhibitors. Any better than NSAIDs? Nguyen A; Chaiton A Can Fam Physician; 2001 Jul; 47():1398-400. PubMed ID: 11494927 [No Abstract] [Full Text] [Related]
16. Renal function trajectories and clinical outcomes in acute heart failure. Givertz MM; Postmus D; Hillege HL; Mansoor GA; Massie BM; Davison BA; Ponikowski P; Metra M; Teerlink JR; Cleland JG; Dittrich HC; O'Connor CM; Cotter G; Voors AA Circ Heart Fail; 2014 Jan; 7(1):59-67. PubMed ID: 24281137 [TBL] [Abstract][Full Text] [Related]
17. New reports on dental analgesics. NSAIDs and cardiovascular effects, celecoxib for dental pain, and a new analgesic--tramadol with acetaminophen. Wynn RL Gen Dent; 2002; 50(3):218-20, 22. PubMed ID: 12116507 [No Abstract] [Full Text] [Related]
18. A side effect of COX-2 inhibitors. Harv Health Lett; 2003 Apr; 28(6):7. PubMed ID: 12777233 [No Abstract] [Full Text] [Related]
19. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib? Underhill JL BMJ; 2005 Dec; 331(7530):1474-5. PubMed ID: 16356996 [No Abstract] [Full Text] [Related]
20. Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Tegeder I; Geisslinger G Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):1-17. PubMed ID: 16586083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]